Related Experiment Video
Updated: May 3, 2026
14:05
Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli
Published on: November 4, 2022
2.4K
Neutrophil Extracellular Traps and Respiratory Disease
Paul T King1,2, Lovisa Dousha1,2
1Monash Lung, Sleep, Allergy and Immunology, Monash Medical Centre, 246 Clayton Rd, Clayton, Melbourne, VIC 3168, Australia.
Journal of Clinical Medicine
|April 27, 2024
Summary
Neutrophil extracellular traps (NETs) are crucial in lung immunity but can cause inflammation and damage. Targeting NETs may offer new treatments for respiratory diseases like COPD and asthma.
Area of Science:
- Immunology
- Pulmonology
- Cell Biology
Background:
- Neutrophil extracellular traps (NETs) and other leukocyte-derived traps play a vital role in the initial immune response to infection.
- These traps are highly inflammatory and implicated in tissue damage, particularly within the pulmonary system due to its anatomical structure facilitating airway and alveolar space extension.
- A growing body of research highlights the involvement of NETs in numerous respiratory diseases, including COPD, cystic fibrosis, asthma, pneumonia, and lung cancer.
Purpose of the Study:
- To provide a comprehensive overview of the role of NETs in respiratory diseases.
- To discuss the potential therapeutic strategies targeting NETs for clinical benefit.
- To differentiate NET formation from other inflammatory cell death pathways.
Main Methods:
- Review of current scientific literature on NETs and respiratory diseases.
- Analysis of the expression and diagnostic challenges related to NETs.
- Examination of early-stage clinical trials for NET-targeting therapeutics.
Main Results:
- NETs are implicated in a wide range of respiratory conditions, including COPD, cystic fibrosis, asthma, pneumonia, COVID-19, and lung cancer.
- The specific mechanisms of NET formation require differentiation from other extracellular DNA-releasing processes.
- Current therapeutic interventions targeting NETs are in the nascent stages of clinical development.
Conclusions:
- NETs are a significant factor in the pathogenesis of various lung diseases.
- Accurate diagnostic methods are needed to distinguish NETs from other inflammatory mediators.
- Targeting NETs presents a promising avenue for future respiratory disease treatments, though further research and clinical validation are essential.
More Related Videos
07:36Author Spotlight: Neutrophil Extracellular Traps Imaging in Human and Mouse Tissues
Published on: August 18, 2023
6.4K
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
596
Related Concept Videos
01:29Microbiota of the Respiratory Tract
55
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
55
01:14Atypical Pneumonia
84
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:29Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24